VietBF - Trump liên kết với Công ty dược Sanofi bên pháp sản xuất thuốc trị Covid nhưng giá trị thấp

08/04/20

Vì sao Trump ra sức quãng bá cho thuốc hydroxychloroquine?
Mời xem Businessinsider:

Trump has a distant financial link to a pharma giant that makes the drug he's been pushing to fight COVID-19 — but it's probably worth less than $1,000

A pharmacy worker wears a protective mask shows a box of Plaquenil on March 25, 2020 in Paris, France. Chesnot/Getty Images

President Donald Trump reportedly has a "small personal financial interest" in a drugmaker that produces hydroxychloroquine, a drug he has been enthusiastically touting as a possible treatment for the new coronavirus, according to a Monday New York Times report.

"As of last year, Mr. Trump reported that his three family trusts each had investments in a Dodge & Cox mutual fund, whose largest holding was in Sanofi," The Times wrote. Sanofi is a French drugmaker that produces hydroxychloroquine pills under the brand name Plaquenil.

A mutual fund is a portfolio that pools together money from several investors and then invests across various asset classes such as stocks, bonds and other forms of debt.

Business Insider followed the paper trail and concluded that the holding has a maximum value of around $1,300, only slightly larger than similar holdings by Trump funds in Google parent Alphabet, FedEx, and the French bank BNP Paribas.

Continue Reading